Major depressive disorder, also known as clinical depression or unipolar depression, is a mental disorder characterized by continuous feelings of sadness, hopelessness and worthlessness that last for more than two weeks and affects a person’s daily activities and relationships. The disorder has high prevalence rates with an estimated 264 million cases globally. The major depressive disorder treatment market comprises antidepressant drugs such as selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), atypical antidepressants and others that help relieve depression symptoms. These drugs work by increasing the levels of serotonin and norepinephrine in the brain which are crucial in maintaining mood balance.
The Global Major Depressive Disorder Treatment Market is estimated to be valued at US$ 13.63 Bn in 2024 and is expected to exhibit a 24% CAGR over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the major depressive disorder treatment are BP Plc, Royal Dutch Shell Plc, Total SE, Chevron Corporation, ExxonMobil Corporation, Engie SA, RWE AG, ON SE, Vattenfall AB, Gazprom, Mitsubishi UFJ Financial Group (MUFG), JPMorgan Chase & Co., Goldman Sachs Group, Inc., Citigroup Inc., Barclays PLC.
The increasing prevalence of major depressive disorder presents lucrative opportunities for key players in the market to expand their product portfolios and geographical reach. According to WHO, depression is one of the leading causes of disability worldwide and almost 280 million people are living with depression globally.
Major players are focusing on expanding in emerging economies with high unmet needs through strategic collaborations, acquisitions and partnerships. The increasing awareness about mental health issues and availability of generic antidepressants are further propelling the growth of major depressive disorder treatment market Trends globally.
Market drivers
The major driver for the growth of major depressive disorder treatment Companies is the increasing prevalence of depression globally. As per WHO, over 300 million people are suffering from depression worldwide. The other key drivers include rising healthcare expenditure, availability of generic drugs, growing mental health awareness, increasing adoption of telehealth and remote care options for treating depression. Furthermore, the presence of robust pipelines with novel therapies in late stages of development is also fueling the market growth.
PEST Analysis
Political: Government initiatives promoting awareness and treatment of depression are encouraging market growth. Reforms in health insurance policies are increasing access to care.
Economic: As economic conditions improve, affordability of quality care is rising which is expanding the market size. Robust GDP growth is allowing higher healthcare spending.
Social: Reducing stigma around mental health issues is leading to greater diagnosis and management of conditions like depression. Social support groups are also helping patients.
Technological: New drugs, therapies and digital tools for remote patient monitoring and self-care are improving outcomes. Advancements in neuroscience are aiding the development of more effective treatments.
The North American region currently holds the largest share of the global major depressive disorder treatment market in terms of value. Key factors driving market growth in North America include rising awareness about depression and availability of advanced treatment options.
The Asia Pacific region is expected to be the fastest growing market during the forecast period. Increasing diagnosis rates supported by improving healthcare infrastructure and expanding insurance coverage are boosting the APAC major depressive disorder treatment market. Growing economies in countries such as China and India are enabling greater investments towards mental healthcare.
*Note:
1. Source: Coherent Market Insights, Public Source, Desk Research
2. We have leveraged AI tools to mine information and compile it

About Author - Money Singh
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc. LinkedIn Profile